When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
IMGN - ImmunoGen GAAP EPS of -$0.10 beats by $0.11 revenue of $38.08M beats by $17.24M
ImmunoGen Inc.
ImmunoGen press release (NASDAQ:IMGN): Q1 GAAP EPS of -$0.10 beats by $0.11. Revenue of $38.08M (+142.5% Y/Y) beats by $17.24M. FY2022 outlook remains unchanged: Revenues between $75M and $85M vs. consensus of $84.98M; Operating expenses between $285Mand $295M; Cash and cash equivalents at December 31, 2022 to be between $24M and $255M.